NCT01175642
Completed
Early Phase 1
Specificity and Generalizability of Cognitive Remediation and Functional Skills Training in Schizophrenia
National Alliance for Research on Schizophrenia and Depression1 site in 1 country75 target enrollmentJuly 2007
Overview
- Phase
- Early Phase 1
- Intervention
- Not specified
- Conditions
- Schizophrenia
- Sponsor
- National Alliance for Research on Schizophrenia and Depression
- Enrollment
- 75
- Locations
- 1
- Primary Endpoint
- neurocognition
- Status
- Completed
- Last Updated
- 9 years ago
Overview
Brief Summary
This randomized trial is examining whether a treatment called cognitive remediation is more effective when it is paired with a social and functional skills training component.
Investigators
Christopher R. Bowie
Professor
National Alliance for Research on Schizophrenia and Depression
Eligibility Criteria
Inclusion Criteria
- •Diagnosis of schizophrenia or schizoaffective disorder
- •Enrolled in outpatient mental health care
- •Reading level of 6th grade or higher
- •English speaking
Exclusion Criteria
- •Medical conditions known to affect cognition
Outcomes
Primary Outcomes
neurocognition
Time Frame: 12 weeks
Secondary Outcomes
- functional competence(36 weeks)
- neurocognition(36 weeks)
Study Sites (1)
Loading locations...
Similar Trials
Completed
Early Phase 1
Cognitive Remediation for Neuropsychological Impairment in Compulsive HoardingHoarding DisorderAttentional ImpairmentNCT01451697Hartford Hospital20
Completed
Not Applicable
Cognitive Remediation Therapy Within a Secure Forensic SettingSchizophreniaSchizoaffective DisorderCognitive DeficitsNCT02360813Central Mental Hospital65
Recruiting
Not Applicable
Providing Therapeutic program focused on restoring cognitive deficits through specific skill training and compensatory strategies to Mild Alzheimer Disease Patients.Health Condition 1: null- Neurologically Diagnosed as Mild Alzheimer Disease.CTRI/2014/04/004550All India Institute of Medical Sciences40
Active, not recruiting
Not Applicable
Cognitive Rehabilitation for Post-COVID-19 Cognitive ImpairmentCognitive ImpairmentNCT05498493Icahn School of Medicine at Mount Sinai67
Completed
Phase 3
Efficacy of Cognitive Remediation in Patients With Schizophrenia or Schizoaffective Disorder Stabilized on LurasidoneSchizophreniaNCT01173874New York State Psychiatric Institute120